Trial intelligence / Profile preview

Bondronat loading doses for pain in breast cancer with bone metastases

NCT02553707Phase 4Completed

Sponsor
Roche
Start
Jul 2006
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ibandronate in bone metastasis, sponsored by Roche. Started Jul 2006; status: completed.

02

Drugs

ibandronate
03

Conditions

bone metastasis

Beyond the preview

Go deeper on NCT02553707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02553707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call